Association of white blood cell parameters with metabolic syndrome: A systematic review and meta-analysis of 168,000 patients

Aysal Mahmood,Hoorain Haider,Saba Samad,Danisha Kumar,Aimen Perwaiz,Rabeea Mushtaq,Abraish Ali,Muhammad Zain Farooq,Hadi Farhat

DOI: https://doi.org/10.1097/md.0000000000037331

IF: 1.6

2024-03-09

Medicine

Abstract:The American Heart Association and the National Heart, Lung, and Blood Institute define metabolic syndrome as a cluster of correlated metabolic risk factors that predispose an individual to the development of atherosclerotic cardiovascular disease. [ 1 ] Several panels of specialists in the field have proposed standard diagnostic criteria to help investigate these risk factors in a clinical setting. Though there are certain differences in the proposed criteria by various authorities, it is generally agreed upon that the main culprits in the development of metabolic syndrome (MetS) are the presence of atherogenic dyslipidemias, i.e., increased low-density lipoprotein and high-density lipoprotein (HDL), elevated blood pressure, hyperglycemia along with visceral adiposity. Thus, the International Diabetes Federation proposes MetS as the presence of central obesity (defined as waist circumference but can be assumed if body mass index > 30 kg/m 2 ) with ethnicity-specific values, plus 2 of the following: Systolic blood pressure ≥ 130 mm Hg or Diastolic ≥ 85 mm Hg, Triglycerides ≥ 150 mg/dL (1.7 mmol/L), HDL < 40 mg/dL (men) (1.03 mmol/L) or < 50 mg/dL (1.29 mmol/L) (women), fasting blood sugar ≥100 mg/dL (5.6 mmol/L) or diagnosed type 2 diabetes mellitus (T2DM). [ 2 ]

medicine, general & internal